Schonfeld Strategic Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-7,807
| Closed | -$1.34M | – | 2717 |
|
|
2021
Q3 | $1.34M | Sell |
7,807
-8,561
| -52% | -$1.47M | 0.01% | 781 |
|
|
2021
Q2 | $2.05M | Buy |
16,368
+8,068
| +97% | +$1.01M | 0.02% | 667 |
|
|
2021
Q1 | $1.13M | Buy |
8,300
+3,200
| +63% | +$434K | 0.01% | 809 |
|
|
2020
Q4 | $653K | Buy |
+5,100
| New | +$653K | 0.01% | 915 |
|
|
2020
Q3 | – | Sell |
-10,726
| Closed | -$1.02M | – | 1720 |
|
|
2020
Q2 | $1.02M | Buy |
+10,726
| New | +$1.02M | 0.03% | 556 |
|
|
2020
Q1 | – | Sell |
-28,611
| Closed | -$1.52M | – | 1644 |
|
|
2019
Q4 | $1.52M | Buy |
28,611
+411
| +1% | +$21.8K | 0.04% | 394 |
|
|
2019
Q3 | $1.11M | Buy |
+28,200
| New | +$1.11M | 0.03% | 447 |
|
|
2017
Q4 | – | Sell |
-144,017
| Closed | -$5.38M | – | 915 |
|
|
2017
Q3 | $5.38M | Buy |
+144,017
| New | +$5.38M | 0.49% | 60 |
|
|
2017
Q2 | – | Sell |
-9,419
| Closed | -$250K | – | 822 |
|
|
2017
Q1 | $250K | Buy |
+9,419
| New | +$250K | 0.03% | 504 |
|